Development of Knowledge Within a Chemical-Toxicological Database to Formulate Novel Computational Approaches for Predicting Repeated Dose Toxicity of Cosmetics-Related Compounds

The European Union (EU) Cosmetics Regulation established the ban on animal testing for cosmetics ingredients. This ban does not assume that all cosmetics ingredients are safe, but that the non-testing procedures (in vitro and in silico) have to be applied for their safety assessment. To this end, the SEURAT-1 cluster was funded by EU 7th Framework Programme and Cosmetics Europe. The COSMOS (Integrated In Silico Models for the Prediction of Human Repeated Dose Toxicity of COSMetics to Optimise Safety) project was initiated as one of the seven consortia of the cluster, with the purpose of facilitating the prediction of human repeated dose toxicity associated with exposure to cosmetics-related compounds through in silico approaches. A critical objective of COSMOS was to address the paucity of publicly available data for cosmetics ingredients and related chemicals. Therefore a database was established containing (i) an inventory of cosmetics ingredients and related structures; (ii) skin permeability/absorption data (route of exposure relevant to cosmetics); and (iii) repeated dose toxicity data. This thesis describes the process of “knowledge discovery from the data”, including collation of the content of the COSMOS database and its subsequent application for developing tools to support the prediction of repeated dose toxicity of cosmetics and related compounds. A rigorous strategy of curation and quality control of chemical records was applied in developing the database (as documented in the Standard Operating Procedure, chapter 2). The chemical space of the cosmetics-related compounds was compared to food-related compounds from the U.S. FDA CFSAN PAFA database using the novel approach combining the analysis of structural features (ToxPrint chemotypes) and physicochemical properties. The cosmetics- and food- specific structural classes related to particular use functions and manifested by distinct physicochemical properties were identified (chapter 3). The novel COSMOS Skin Permeability Database containing in vivo and in vitro skin permeability/absorption data was developed by integrating existing databases and enriching them with new data for cosmetics harvested from regulatory documents and scientific literature (chapter 4). Compounds with available data on human in vitro maximal flux (JMAX) were subsequently extracted from the developed database and analysed in terms of their structural features (ToxPrint chemotypes) and physicochemical properties. The profile of compounds exhibiting low or high skin permeability potential was determined. The results of this analysis can support rapid screening and classification of the compounds without experimental data (chapter 5). The new COSMOS oral repeated dose toxicity database was established through consolidation of existing data sources and harvesting new regulatory documents and scientific literature. The unique data structure of the COSMOS oRepeatToxDB allows capturing all toxicological effects observed at particular dose levels and sites, which are hierarchically differentiated as organs, tissues, and cells (chapter 6). Such design of this database enabled the development of liver toxicity ontology, followed by mechanistic mining of in vivo data (chapter 7). As a result, compounds associated with liver steatosis, steatohepatitis and fibrosis phenotypic effects were identified and further analysed. The probable mechanistic reasoning for toxicity (Peroxisome Proliferator-Activated Receptor gamma (PPAR ) activation) was formulated for two hepatotoxicants, namely 1,3-bis-(2,4-diaminophenoxy)-propane and piperonyl butoxide. Key outcomes of this thesis include an extensive curated database, Standard Operating Procedures, skin permeability potential classification rules, and the set of structural features associated with liver steatosis. Such knowledge is particularly important in the light of the 21st Century Toxicology (NRC, 2007) and the ongoing need to move away from animal toxicity testing to non-testing alternatives.

[1]  Michael H. Abraham,et al.  Hydrogen bonding part 46: a review of the correlation and prediction of transport properties by an lfer method: physicochemical properties, brain penetration and skin permeability , 1999 .

[2]  I Tuncer Degim,et al.  New tools and approaches for predicting skin permeability. , 2006, Drug discovery today.

[3]  N. F. Noy,et al.  Ontology Development 101: A Guide to Creating Your First Ontology , 2001 .

[4]  Michael S. Roberts,et al.  Simple Rules Defining the Potential of Compounds for Transdermal Delivery or Toxicity , 2004, Pharmaceutical Research.

[5]  A. Michaels,et al.  Drug permeation through human skin: Theory and invitro experimental measurement , 1975 .

[6]  Clifford Goodman,et al.  Food and Drug Administration Center for Food Safety and Applied Nutrition , 1988 .

[7]  T. Vanhaecke,et al.  Screening of repeated dose toxicity data present in SCC(NF)P/SCCS safety evaluations of cosmetic ingredients , 2012, Archives of Toxicology.

[8]  R. Cattell.  The description of personality: basic traits resolved into clusters. , 1943 .

[9]  J. Brecher.  Name=Struct: A Practical Approach to the Sorry State of Real-Life Chemical Nomenclature , 1999, J. Chem. Inf. Comput. Sci..

[10]  Peter P. Chen,et al.  Entity-Relationship Modeling : Historical Events , Future Trends , and Lessons Learned , 2002 .

[11]  Bernard Testa,et al.  Quantitative Structure-Permeation Relationships (QSPeRs) to Predict Skin Permeation: A Critical Evaluation , 2004, Pharmaceutical Research.

[12]  A. Bunge,et al.  A New Method for Estimating Dermal Absorption from Chemical Exposure: 2. Effect of Molecular Weight and Octanol-Water Partitioning , 2004, Pharmaceutical Research.

[13]  COMMITTEE FOR HUMAN MEDICINAL PRODUCTS (CHMP) REFLECTION PAPER ON PHARMACOGENOMIC SAMPLES, TESTING AND DATA HANDLING DRAFT AGREED BY THE PGWP WORKING PARTY October 2006 ADOPTION BY CHMP FOR RELEASE FOR CONSULTATION , 2006 .

[14]  Teuvo Kohonen,et al.  Self-organized formation of topologically correct feature maps , 2004, Biological Cybernetics.

[15]  R. Sharma,et al.  Percutaneous penetration of diethanolamine through human skin in vitro: application from cosmetic vehicles. , 2005, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[16]  J. Bouwstra,et al.  The important role of stratum corneum lipids for the cutaneous barrier function. , 2014, Biochimica et biophysica acta.

[17]  J. C. Madden.  Chapter 5:Sources of Chemical Information, Toxicity Data and Assessment of Their Quality , 2013 .

[18]  Lujia Han,et al.  An evaluation of mathematical models for predicting skin permeability. , 2008, Journal of pharmaceutical sciences.

[19]  G. P. Martin,et al.  Variability in human skin permeability in vitro: comparing penetrants with different physicochemical properties. , 2007, Journal of pharmaceutical sciences.

[20]  R Kroes,et al.  Application of the threshold of toxicological concern (TTC) to the safety evaluation of cosmetic ingredients. , 2007, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[21]  K. A. Walters,et al.  Dermatological And Transdermal Formulations , 2002 .

[22]  G. Menon,et al.  International Journal of Pharmaceutics , 2012 .

[23]  Chihae Yang,et al.  The Art of Data Mining the Minefields of Toxicity Databases to Link Chemistry to Biology , 2006 .

[24]  J. Contrera,et al.  A new highly specific method for predicting the carcinogenic potential of pharmaceuticals in rodents using enhanced MCASE QSAR-ES software. , 1998, Regulatory toxicology and pharmacology : RTP.

[25]  Samir Mitragotri,et al.  Modeling skin permeability to hydrophilic and hydrophobic solutes based on four permeation pathways. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[26]  Heikki Mannila,et al.  Principles of Data Mining , 2001, Undergraduate Topics in Computer Science.

[27]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[28]  M. Bloomston,et al.  Liver anatomy. , 2010, The Surgical clinics of North America.

[29]  P. Elias,et al.  Percutaneous transport in relation to stratum corneum structure and lipid composition. , 1981, The Journal of investigative dermatology.

[30]  Romualdo Benigni,et al.  The second National Toxicology Program comparative exercise on the prediction of rodent carcinogenicity: definitive results. , 2004, Mutation research.

[31]  Daniel L Villeneuve,et al.  Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment , 2010, Environmental toxicology and chemistry.

[32]  Claus-Michael Lehr,et al.  Modeling the human skin barrier--towards a better understanding of dermal absorption. , 2013, Advanced drug delivery reviews.

[33]  Russell O. Potts,et al.  Predicting Skin Permeability , 1992, Pharmaceutical Research.

[34]  Y. Lo,et al.  Noninvasive Characterization of Regional Variation in Drug Transport into Human Stratum Corneum in Vivo , 2003, Pharmaceutical Research.

[35]  Chihae Yang,et al.  In vivo data mining and in silico metabolic profiling to predict diverse hepatotoxic phenotypes: Case study of piperonyl butoxide , 2015 .

[36]  Nigel Greene,et al.  Computer systems for the prediction of toxicity: an update. , 2002, Advanced drug delivery reviews.

[37]  Johann Gasteiger,et al.  Neural networks in chemistry and drug design , 1999 .

[38]  K. Brain,et al.  Percutaneous penetration of dimethylnitrosamine through human skin in vitro: application from cosmetic vehicles. , 1995, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[39]  W. Lautt.  Hepatic Circulation: Physiology and Pathophysiology , 2009 .

[40]  Johannes M Nitsche,et al.  A multiphase microscopic diffusion model for stratum corneum permeability. I. Formulation, solution, and illustrative results for representative compounds. , 2006, Journal of pharmaceutical sciences.

[41]  OECD GUIDELINES FOR THE TESTING OF CHEMICALS , 2008 .

[42]  Howard I Maibach,et al.  Estimating skin permeability from physicochemical characteristics of drugs: a comparison between conventional models and an in vivo-based approach. , 2009, International journal of pharmaceutics.

[43]  Johann Gasteiger,et al.  New Publicly Available Chemical Query Language, CSRML, To Support Chemotype Representations for Application to Data Mining and Modeling , 2015, J. Chem. Inf. Model..

[44]  H. Schaefer,et al.  Percutaneous Absorption of Sunscreens in vitro: Interspecies Comparison, Skin Models and Reproducibility Aspects , 2000, Skin Pharmacology and Physiology.

[45]  W. Roberts,et al.  Correlation of aqueous and lipid solubilities with flux for prodrugs of 5-fluorouracil, theophylline, and 6-mercaptopurine: A Potts-Guy approach. , 1999, Journal of pharmaceutical sciences.

[46]  Yi Sun,et al.  An evaluation of the potential of linear and nonlinear skin permeation models for the prediction of experimentally measured percutaneous drug absorption , 2012, The Journal of pharmacy and pharmacology.

[47]  M. Jakubowski,et al.  Calculating the dermal flux of chemicals with OELs based on their molecular structure: An attempt to assign the skin notation. , 2010, Environmental toxicology and pharmacology.

[48]  M. Krishna.  Microscopic anatomy of the liver , 2013, Clinical liver disease.

[49]  Brian W. Barry,et al.  Variations in permeability of human skin within and between specimens , 1984 .

[50]  Revised Guidance Document on Developing and Assessing Adverse Outcome Pathways , 2013 .

[51]  Pitchai Balakumar,et al.  A step ahead of PPARγ full agonists to PPARγ partial agonists: therapeutic perspectives in the management of diabetic insulin resistance. , 2015, European journal of pharmacology.

[52]  H I Maibach,et al.  In vivo percutaneous penetration of some organic compounds related to anatomic site in humans: predictive assessment by the stripping method. , 1987, Journal of pharmaceutical sciences.

[53]  Howard I. Maibach,et al.  OECD GUIDELINES FOR THE TESTING OF CHEMICALS In Vitro Skin Corrosion: Transcutaneous Electrical Resistance Test Method , 2013 .

[54]  Luc De Raedt,et al.  Data Mining and Machine Learning Techniques for the Identification of Mutagenicity Inducing Substructures and Structure Activity Relationships of Noncongeneric Compounds , 2004, J. Chem. Inf. Model..

[55]  Eric Deconinck,et al.  Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds. , 2007, Bioorganic & medicinal chemistry.

[56]  Mark T. D. Cronin,et al.  Data mining toxicity effects through an ontology approach to investigate toxicity mode of action , 2013 .

[57]  G. Myatt,et al.  Chem-tox informatics: data mining using a medicinal chemistry building block approach. , 2001, Current opinion in drug discovery & development.

[58]  G P Moss,et al.  Investigation of the mechanism of flux across human skin in vitro by quantitative structure-permeability relationships. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[59]  J. Froines,et al.  UNITED STATES ENVIRONMENTAL PROTECTION AGENCY , 1995 .

[60]  Heng Tao Shen,et al.  Principal Component Analysis , 2009, Encyclopedia of Biometrics.

[61]  Roberto Todeschini,et al.  Handbook of Molecular Descriptors , 2002 .

[62]  Visualization of Chemical Space Using Principal Component Analysis , 2014 .

[63]  J. Ladero,et al.  Liver fibrosis. , 2018, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[64]  E. Rhodes,et al.  XXXIV. On lines and planes of closest fit , 1927 .

[65]  Mark T D Cronin,et al.  Quantitative structure-permeability relationships for percutaneous absorption: re-analysis of steroid data. , 2002, International journal of pharmaceutics.

[66]  W. Sterry,et al.  Variations of hair follicle size and distribution in different body sites. , 2004, The Journal of investigative dermatology.

[67]  Gabriel Wittum,et al.  Detailed modeling of skin penetration--an overview. , 2013, Advanced drug delivery reviews.

[68]  John F. Sowa,et al.  Knowledge representation: logical, philosophical, and computational foundations , 2000 .

[69]  M. Ashburner,et al.  The OBO Foundry: coordinated evolution of ontologies to support biomedical data integration , 2007, Nature Biotechnology.

[70]  Guidance on information requirements and chemical safety assessment , 2008 .

[71]  M. Cronin,et al.  Improving the applicability of (Q)SARs for percutaneous penetration in regulatory risk assessment , 2008, Human & experimental toxicology.

[72]  Brian W. Barry,et al.  On the non-Gaussian distribution of human skin permeabilities , 1992 .

[73]  David Weininger,et al.  SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules , 1988, J. Chem. Inf. Comput. Sci..

[74]  Michael S. Roberts,et al.  Skin Solubility Determines Maximum Transepidermal Flux for Similar Size Molecules , 2009, Pharmaceutical Research.

[75]  Yuri Dancik,et al.  Design and performance of a spreadsheet-based model for estimating bioavailability of chemicals from dermal exposure. , 2013, Advanced drug delivery reviews.

[76]  Marvin Johnson,et al.  Concepts and applications of molecular similarity , 1990 .

[77]  R Daniel Benz,et al.  Toxicological and clinical computational analysis and the US FDA/CDER , 2007, Expert opinion on drug metabolism & toxicology.

[78]  D. Young,et al.  Are the Chemical Structures in Your QSAR Correct , 2008 .

[79]  P Sartorelli,et al.  In vitro predictions of skin absorption of caffeine, testosterone, and benzoic acid: a multi-centre comparison study. , 2004, Regulatory toxicology and pharmacology : RTP.

[80]  J. Bensouilah,et al.  Aromadermatology: Aromatherapy in the Treatment and Care of Common Skin Conditions , 2001 .

[81]  G Xu,et al.  Selection of appropriate training and validation set chemicals for modelling dermal permeability by U-optimal design , 2013, SAR and QSAR in environmental research.

[82]  Andrew P Worth,et al.  Computational toxicology at the European Commission's Joint Research Centre , 2010, Expert opinion on drug metabolism & toxicology.

[83]  E. F. Codd,et al.  A Relational Model for Large Shared Data Banks , 1970 .

[84]  Alexander Tropsha,et al.  Trust, But Verify: On the Importance of Chemical Structure Curation in Cheminformatics and QSAR Modeling Research , 2010, J. Chem. Inf. Model..

[85]  D. Blacker.  Food for thought. , 2013, JAMA neurology.

[86]  Stephen R. Heller,et al.  InChI - the worldwide chemical structure identifier standard , 2013, Journal of Cheminformatics.

[87]  C. Cordella.  PCA: The Basic Building Block of Chemometrics , 2012 .

[88]  Robert Fraczkiewicz,et al.  Tales from the war on error: the art and science of curating QSAR data , 2015, Journal of Computer-Aided Molecular Design.

[89]  Samir Mitragotri,et al.  Mathematical models of skin permeability: an overview. , 2011, International journal of pharmaceutics.

[90]  Timothy R. Gerrity,et al.  Principles of route-to-route extrapolation for risk assessment : proceedings of the Workshops on Principles of Route-to-Route Extrapolation for Risk Assessment held March 19-21, 1990, in Hilton Head, South Carolina and July 10-11, 1990, in Durham, North Carolina , 1990 .

[91]  M. Cheeseman,et al.  Structure-activity relationship analysis tools: validation and applicability in predicting carcinogens. , 2008, Regulatory toxicology and pharmacology : RTP.

[92]  Aoife A. Gowen,et al.  Data handling in hyperspectral image analysis , 2011 .

[93]  A. Bunge,et al.  A New Method for Estimating Dermal Absorption from Chemical Exposure. 1. General Approach , 1993, Pharmaceutical Research.

[94]  R. Scheuplein,et al.  Mechanism of percutaneous absorption. II. Transient diffusion and the relative importance of various routes of skin penetration. , 1967, The Journal of investigative dermatology.

[95]  Chihae Yang,et al.  Computational Toxicology Approaches at the US Food and Drug Administration a , 2009, Alternatives to laboratory animals : ATLA.

[96]  W. Roberts,et al.  Prediction of transdermal flux of prodrugs of 5-fluorouracil, theophylline, and 6-mercaptopurine with a series/parallel model. , 2000, Journal of pharmaceutical sciences.

[97]  Petko Alov,et al.  Modes-of-Action Related to Repeated Dose Toxicity: Tissue-Specific Biological Roles of PPARγ Ligand-Dependent Dysregulation in Nonalcoholic Fatty Liver Disease , 2014, PPAR research.

[98]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[99]  R D Benz,et al.  Priority-based assessment of food additives database of the U.S. Food and Drug Administration Center for Food Safety and Applied Nutrition. , 1991, Environmental health perspectives.

[100]  M. Abraham,et al.  Human skin permeation and partition: general linear free-energy relationship analyses. , 2004, Journal of pharmaceutical sciences.

[101]  Andrew P Worth,et al.  The application of molecular modelling in the safety assessment of chemicals: A case study on ligand-dependent PPARγ dysregulation. , 2017, Toxicology.

[102]  U. Tillmann,et al.  A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. , 1997, Regulatory toxicology and pharmacology : RTP.

[103]  R Benigni,et al.  Understanding Genetic Toxicity Through Data Mining: The Process of Building Knowledge by Integrating Multiple Genetic Toxicity Databases , 2008, Toxicology mechanisms and methods.

[104]  D. Green,et al.  Percutaneous penetration of N-nitroso-N-methyldodecylamine through human skin in vitro: application from cosmetic vehicles. , 1997, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[105]  W. Russell,et al.  Ethical and Scientific Considerations Regarding Animal Testing and Research , 2011, PloS one.

[106]  OECD Series on Adverse Outcome Pathways No . 1 Users ' Handbook supplement to the Guidance Document for developing and assessing Adverse Outcome Pathways OECD , 2018 .

[107]  Johannes M Nitsche,et al.  A multiphase microscopic diffusion model for stratum corneum permeability. II. Estimation of physicochemical parameters, and application to a large permeability database. , 2007, Journal of pharmaceutical sciences.

[108]  J. Riviere,et al.  The effect of formulations and experimental conditions on in vitro human skin permeation-Data from updated EDETOX database. , 2012, International journal of pharmaceutics.

[109]  M T D Cronin,et al.  Quantitative structure-permeability relationships (QSPRs) for percutaneous absorption. , 2002, Toxicology in vitro : an international journal published in association with BIBRA.

[110]  J. Nightingale,et al.  Variation of human skin permeation in vitro: Ionic vs neutral compounds , 1993 .

[111]  Steven K. Gibb.  Toxicity testing in the 21st century: a vision and a strategy. , 2008, Reproductive toxicology.

[112]  H I Maibach,et al.  Skin surface lipid and skin friction: relation to age, sex and anatomical region. , 1995, Skin pharmacology : the official journal of the Skin Pharmacology Society.

[113]  Michael S Roberts,et al.  Molecular size as the main determinant of solute maximum flux across the skin. , 2004, The Journal of investigative dermatology.